Jul 2026· Biochimica et Biophysica Acta - General Subjects· pp.
130984
· 0 citations· 37 references
Medicine
TL;DR
Fosl2 or c-Jun knockdown reduced cerebral infarction volume, alleviated blood-brain barrier injury, and suppressed oxidative stress and ERS, thereby contributing to ICI.
Abstract
Objective
Ischemic cerebral infarction (ICI) results in high disability and mortality rates. This study aims to validate that the Fosl2/c-Jun dimer promotes ICI via the transcriptional activation of Lcn2.
Methods
Differentially expressed genes were identified and screened in the microvasculature of sham-operated and transient middle cerebral artery occlusion/reperfusion (tMCAO/R) mouse brains through bioinformatics analysis. Mouse models were established via tMCAO/R surgery, while mouse brain-derived Endothelial cells.3 (bEnd.3) were exposed to oxygen-glucose deprivation/reoxygenation (OGD/R). Fosl2 and c-Jun expression levels were detected, and their interaction was validated. Knockdown of Fosl2 or c-Jun was performed in tMCAO/R mice and bEnd.3 cells, followed by detection of AP-1 transcriptional activity, oxidative stress levels, infarct extent, blood-brain barrier integrity, and endoplasmic reticulum stress (ERS)-related proteins. The downstream target of Fosl2 was predicted using bioinformatics databases. Lcn2 expression was detected via RT-qPCR and Western blot. The transcriptional regulatory relationship was validated through dual-luciferase and ChIP assays.
Results
Fosl2, c-Jun, and Lcn2 were highly expressed in mouse and cell models of ICI. Fosl2 interacted with c-Jun, and the Fosl2/c-Jun dimer transcriptionally activated Lcn2 by binding to its promoter. Fosl2 or c-Jun knockdown reduced cerebral infarction volume, alleviated blood-brain barrier injury, and suppressed oxidative stress and ERS. Overexpression of Lcn2 partially attenuated the suppressive effects of Fosl2 or c-Jun knockdown.
Conclusion
Fosl2/c-Jun dimer induces Lcn2 transcription activation to promote oxidative stress and ERS, thereby contributing to ICI. This study reveals a potential mechanism for the clinical treatment of ICI.
The findings indicate that an increase in oxidative stress parameters arose at the earlier phase of ischemic neurodegenerative processes, while SREBP-1 expression increased in the mid-phase.
M. Dağdeviren, M. Işcan, P. Kelicen-Uğur· Turkish Journal of Biochemis...· 0 citations
Ischemic stroke is a prevalent cerebrovascular disease and remains a major cause of chronic disability and death worldwide. Runt-related transcription factor-1 (RUNX1) is a critical member of the core-binding factor family abnormally elevated in ischemic brain tissue. However, the exact roles of RUNX1 and its underlyin...
The activation of endoplasmic reticulum stress (ERS), specifically the PERK/eIF2α/CHOP signaling, is a recognized consequence of ischemic stroke. However, the roles and mechanisms of CRM‐1 regulating ERS in stroke are poorly elucidated. A murine model of stroke was generated via transient middle cerebral artery occlusi...
Chujuan Liu, Chen Li, Tingting Hu et al.· The FASEB Journal· 0 citations
Abstract Neonatal hypoxic-ischemic brain damage (HIBD) is a major cause of neurological disability. This study investigated the role of the transcription factor specificity protein 1 (SP1) and its target, Acyl-CoA Synthetase Long-Chain Family Member 4 (ACSL4), in regulating ferroptosis in neonatal HIBD. Using a neonata...
Shuting Chang, Weiqing Huang, Biao Yi et al.· ASN Neuro· 0 citations
Functional experiments revealed that silencing miR-9–5p protected against cerebral ischemia/reperfusion injury and suppressed NLRP3 inflammasome activation following IS, suggesting that its blockade could be a potential therapeutic strategy for ischemic brain injury.